<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="31109">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02701712</url>
  </required_header>
  <id_info>
    <org_study_id>14-8210-CE</org_study_id>
    <nct_id>NCT02701712</nct_id>
  </id_info>
  <brief_title>Receiving Radiation Therapy in the MRgRT Research Facility</brief_title>
  <acronym>MRgRT</acronym>
  <official_title>Receiving Radiation Therapy in the MRgRT Research Facility</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Health Network, Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the technical performance of magnetic-resonance guided
      radiotherapy (MRgRT) facility at the Princess Margaret Cancer Centre and the impact on the
      workflow of the clinical team in this facility.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Anticipated">February 2018</completion_date>
  <primary_completion_date type="Anticipated">February 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of planned patients receiving treatment in the MRgRT facility</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Measure tumor size before, during and after radiotherapy</measure>
    <time_frame>2 years</time_frame>
    <description>Collect and analyze imaging data before, during and after radiotherapy, and the related treatment data</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Solid Tumors and Metastatic Lesions</condition>
  <arm_group>
    <arm_group_label>Magnetic resonance - guided radiation therapy (MRgRT)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Magnetic resonance (MR) - guided radiation therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Magnetic resonance - guided radiation therapy (MRgRT)</intervention_name>
    <description>Use of magnetic resonance (MR) visualization for interventional radiotherapy in cancer patients</description>
    <arm_group_label>Magnetic resonance - guided radiation therapy (MRgRT)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ability to provide informed consent

          -  Planned to receive clinical intervention (imaging or treatment) in the MRgRT facility

          -  At least 18 years of age

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Michael Milosevic, MD</last_name>
    <phone>416-946-4501</phone>
    <phone_ext>2932</phone_ext>
    <email>mike.milosevic@rmp.uhn.on.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Health Network</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2M9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mike Milosevic, MD</last_name>
      <phone>416-946-4501</phone>
      <phone_ext>2932</phone_ext>
      <email>mike.milosevic@rmp.uhn.on.ca</email>
    </contact>
    <investigator>
      <last_name>Mike Milosevic, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <lastchanged_date>October 31, 2016</lastchanged_date>
  <firstreceived_date>February 22, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>magnetic resonance</keyword>
  <keyword>external beam radiotherapy</keyword>
  <keyword>brachytherapy</keyword>
  <keyword>radiotherapy</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
